IceCure Medical Ltd

NasdaqCM:ICCM Stock Report

Market Cap: US$29.6m

IceCure Medical Management

Management criteria checks 4/4

IceCure Medical's CEO is Eyal Shamir, appointed in Sep 2016, has a tenure of 8.17 years. total yearly compensation is $553.00K, comprised of 75.3% salary and 24.7% bonuses, including company stock and options. directly owns 1.05% of the company’s shares, worth $311.55K. The average tenure of the management team and the board of directors is 5.9 years and 6 years respectively.

Key information

Eyal Shamir

Chief executive officer

US$553.0k

Total compensation

CEO salary percentage75.3%
CEO tenure8.2yrs
CEO ownership1.1%
Management average tenure5.9yrs
Board average tenure6yrs

Recent management updates

Recent updates

Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Invest In Growth?

Jul 31
Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Invest In Growth?

We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate

Nov 29
We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate

Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?

Aug 08
Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?

IceCure gains 19% on seeking FDA nod for cancer treatment

Oct 19

IceCure files application for approval of ProSense in Canada for tumors

Jul 25

IceCure Medical: Advancing Cryotherapy For Cancer Treatment

Jan 25

CEO Compensation Analysis

How has Eyal Shamir's remuneration changed compared to IceCure Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$14m

Mar 31 2024n/an/a

-US$14m

Dec 31 2023US$553kUS$416k

-US$15m

Sep 30 2023n/an/a

-US$16m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$16m

Dec 31 2022US$658kUS$467k

-US$17m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$13m

Dec 31 2021US$489kUS$426k

-US$10m

Sep 30 2021n/an/a

-US$8m

Jun 30 2021n/an/a

-US$6m

Mar 31 2021n/an/a

-US$4m

Dec 31 2020US$420kUS$370k

-US$4m

Sep 30 2020n/an/a

-US$4m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$4m

Dec 31 2019n/an/a

-US$5m

Sep 30 2019n/an/a

-US$5m

Jun 30 2019n/an/a

-US$4m

Mar 31 2019n/an/a

-US$4m

Dec 31 2018US$350kUS$251k

-US$4m

Sep 30 2018n/an/a

-US$3m

Jun 30 2018n/an/a

-US$3m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$312kUS$259k

-US$3m

Compensation vs Market: Eyal's total compensation ($USD553.00K) is about average for companies of similar size in the US market ($USD652.28K).

Compensation vs Earnings: Eyal's compensation has been consistent with company performance over the past year.

CEO

Eyal Shamir (63 yo)

8.2yrs

Tenure

US$552,996

Compensation

Mr. Eyal Shamir serves as Chief Executive Officer and Director at IceCure Medical Ltd. since September 2016 and December 2017 respectively. Mr. Shamir served as Chief Executive Officer of Tadbik Pack Ltd.,...

Leadership Team

NamePositionTenureCompensationOwnership
Eyal Shamir
CEO & Director8.2yrsUS$553.00k1.05%
$ 311.6k
Ronen Tsimerman
CFO & COO7.5yrsUS$405.26k0.62%
$ 184.0k
Tlalit Tel-Tzure
Vice President of Business Development & Global Marketing5.9yrsUS$320.70k0.32%
$ 93.6k
Merav Dotan
Vice President of Human Resources3yrsUS$282.17k0.12%
$ 34.8k
Galit Malik
Vice President of Operations & Service1.9yrsno data0.11%
$ 33.7k

5.9yrs

Average Tenure

55yo

Average Age

Experienced Management: ICCM's management team is seasoned and experienced (5.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Eyal Shamir
CEO & Director6.9yrsUS$553.00k1.05%
$ 311.6k
Sharon Levita
Independent External Director5.2yrsUS$205.58kno data
Oded Tamir
Independent External Director11.2yrsno data0.020%
$ 6.0k
Ron Mayron
Chairman of the Board6.9yrsUS$62.23k0.45%
$ 133.2k
Chun Hung Chan
Independent Director1.9yrsno datano data
Yang Huang
Director4.6yrsno data0.15%
$ 43.9k

6.0yrs

Average Tenure

61yo

Average Age

Experienced Board: ICCM's board of directors are considered experienced (6 years average tenure).